Home > Research > Biomedical and Life Sciences > Press

Research

View graph of relations

Biomedical and Life Sciences

101 - 200 out of 763Page size: 100
RSS feed of this list
Sort by: Date

  1. Monkeypox in UK

    Munir, M.

    24/05/22

    1 Media production

    Press/Media: Research

  2. Trend to use smallpox vaccine for groups at risk of monkeypox

    Rohaim, M.

    23/05/22

    1 Media production

    Press/Media: TV Interview/Appearance

  3. Virus researcher reveals common method that helps spread monkeypox

    Rohaim, M.

    23/05/22

    1 Media production

    Press/Media: TV Interview/Appearance

  4. Monkeypox emergence

    Munir, M.

    22/05/22

    1 Media production

    Press/Media: Research

  5. Sixty seconds on . . . nasal vaccines

    Munir, M.

    6/05/22

    1 Media production

    Press/Media: Newspaper Article

  6. UK removes social distance requirements in GP and hospital waiting rooms

    Munir, M.

    21/04/22

    1 Media production

    Press/Media: Research

  7. Zero-covid to vaccine approaches

    Munir, M.

    14/04/22

    1 Media production

    Press/Media: Research

  8. MSc students gain experience in scientific writing by co-authoring a paper on SARS-CoV-2

    Munir, M.

    30/03/22

    1 Media production

    Press/Media: Newspaper Article

  9. Lancaster researchers investigate the virology of Coronaviruses

    Munir, M.

    23/02/22

    1 Media production

    Press/Media: Newspaper Article

  10. New partnerships to support Lancaster COVID-19 vaccine rollout

    Munir, M.

    18/02/22

    1 Media production

    Press/Media: Newspaper Article

  11. BA.2 is next challenge after BA.1, both represent Omicron

    Munir, M.

    3/02/22

    1 Media production

    Press/Media: Research

  12. Animals in contact with humans must be vaccinated with COVID-19 vaccine

    Rohaim, M.

    20/01/22

    1 Media production

    Press/Media: TV Interview/Appearance

  13. Responding to a pandemic UK universities’ research into COVID-19: Developing a COVID-19 vaccine nasal spray

    Munir, M.

    26/12/21

    1 Media production

    Press/Media: Newspaper Article

  14. Omicron cases in the UK

    Munir, M.

    24/12/21

    1 Media production

    Press/Media: Research

  15. Omicron cases, pills and vaccine distribution

    Munir, M.

    24/12/21

    1 Media production

    Press/Media: Research

  16. Omicron

    Munir, M.

    28/11/21 → 23/12/21

    7 Media contributions

    Press/Media: Research

  17. Omicron and COVID-19 in general

    Munir, M.

    23/12/21

    3 Media contributions

    Press/Media: Research

  18. Omicron and vaccines distribution

    Munir, M.

    23/12/21

    1 Media production

    Press/Media: Research

  19. Omicron as general

    Munir, M.

    14/12/21

    1 Media production

    Press/Media: Research

  20. COVID-19 in General

    Munir, M.

    6/11/21 → 14/12/21

    2 Media contributions

    Press/Media: Research

  21. Lancaster University joins forces with British biomedical firm ViraCorp to create ‘vaccine for the world’

    Munir, M.

    14/12/21

    1 Media production

    Press/Media: Newspaper Article

  22. Lancaster University joins forces with British biomedical firm ViraCorp to create ‘vaccine for the world’

    Rohaim, M.

    14/12/21

    1 Media production

    Press/Media: Research

  23. November 2021 Coronavirus

    Munir, M.

    30/11/21

    1 Media production

    Press/Media: Research

  24. COVID-19 pills, vaccines for LMIC

    Munir, M.

    19/11/21

    1 Media production

    Press/Media: Research

  25. COVID-19 pill from Merk is approved

    Munir, M.

    4/11/21 → 5/11/21

    4 Media contributions

    Press/Media: Research

  26. COVID-19 pill from Merk is approved, a gene making southeast Asian more vulnerable.

    Munir, M.

    4/11/21

    1 Media production

    Press/Media: Research

  27. PPE bussiness created 100 jobs

    Munir, M.

    28/10/21

    1 Media production

    Press/Media: Research

  28. Emerging cases of COVID-19 in the UK and prospect of Plan B

    Munir, M.

    21/10/21 → 22/10/21

    2 Media contributions

    Press/Media: Research

  29. Cases of COVID in the UK are more than ever, going into winter and Delta AY.4.2 is emerging

    Munir, M.

    20/10/21

    2 Media contributions

    Press/Media: Research

  30. Pfizer antiviral drug

    Munir, M.

    2/10/21

    1 Media production

    Press/Media: Research

  31. Cuba started vaccinating 2 year plus children

    Munir, M.

    9/09/21

    1 Media production

    Press/Media: Research

  32. Vaccines shortage in Africa and Biden to start Global Vaccine Summit, Pfizer started COVID+Influenza Vaccine

    Munir, M.

    9/09/21

    1 Media production

    Press/Media: Research

  33. Vaccines in Africa and Global Warming

    Munir, M.

    8/09/21

    1 Media production

    Press/Media: Research

  34. Our COVID-19 Vaccine Coverage Documentary

    Munir, M.

    18/08/21

    1 Media production

    Press/Media: Research

  35. Our COVID-19 Vaccine Coverage Live

    Munir, M.

    18/08/21

    1 Media production

    Press/Media: Research

  36. Lancaster University COVID-19 Intranasal Vaccine

    Rohaim, M.

    18/08/21

    1 Media production

    Press/Media: TV Interview/Appearance

  37. Lancaster University intranasal vaccine offers promise to block COVID-19 where it starts

    Munir, M.

    14/08/21

    1 Media production

    Press/Media: Newspaper Article

  38. Lancaster University intranasal vaccine offers promise to block COVID-19 where it starts

    Rohaim, M.

    10/08/21

    1 Media production

    Press/Media: Research

  39. Clarification the symptoms of the "Delta" variant strain of the Coronavirus ... After its appearance, the World Health Organization recommended re-evaluating vaccines

    Rohaim, M.

    1/08/21

    1 Media production

    Press/Media: TV Interview/Appearance

  40. ViraCorp partners with Lancaster University to test and develop innovative antiviral technologies

    Munir, M.

    8/07/21

    1 Media production

    Press/Media: Newspaper Article

  41. Delta variant and its impact

    Munir, M.

    5/07/21 → 8/07/21

    2 Media contributions

    Press/Media: Research

  42. Threats of delta variant on global situation of COVID

    Munir, M.

    7/07/21

    1 Media production

    Press/Media: Research

  43. Delta variant and opening up in the UK

    Munir, M.

    6/07/21

    1 Media production

    Press/Media: Research

  44. Pfizer vaccine 64% effective against delta variants

    Munir, M.

    6/07/21

    1 Media production

    Press/Media: Research

  45. Release of all restriction in the UK on 19th July

    Munir, M.

    6/07/21

    1 Media production

    Press/Media: Research

  46. Delta variant and its impact globally and vaccine coverage

    Munir, M.

    5/07/21

    1 Media production

    Press/Media: Research

  47. UK set to fully open on 19th July 2021

    Munir, M.

    5/07/21

    1 Media production

    Press/Media: Research

  48. Vaccine incentives and compulsory vaccination

    Munir, M.

    5/07/21

    1 Media production

    Press/Media: Research

  49. Situation of UK and Delta variant

    Munir, M.

    20/06/21

    1 Media production

    Press/Media: Research

  50. Sun safety

    Allinson, S.

    14/05/21 → 18/05/21

    2 Media contributions

    Press/Media: Research

  51. How to avoid sun damage after months in lockdown

    Allinson, S.

    14/05/21

    1 Media production

    Press/Media: Newspaper Article

  52. Situation of the UK

    Munir, M.

    5/05/21

    1 Media production

    Press/Media: Research

  53. Coronavirus delta variant

    Munir, M.

    5/05/21

    1 Media production

    Press/Media: Research

  54. Indian variant, India in Red list, Boris cancelled India trip

    Munir, M.

    20/04/21

    9 Media contributions

    Press/Media: Research

  55. J&J Vaccine pause due to blood clotting issues

    Munir, M.

    13/04/21 → 14/04/21

    2 Media contributions

    Press/Media: Research

  56. AstraZenca vaccine and blood clotting

    Munir, M.

    6/04/20 → 8/04/21

    12 Media contributions

    Press/Media: Research

  57. AstraZenca vaccine and blood clotting and setback to global vaccination compaign

    Munir, M.

    8/04/21

    2 Media contributions

    Press/Media: Research

  58. Testing general public twice a week

    Munir, M.

    7/04/21

    1 Media production

    Press/Media: Research

  59. AstraZenca vaccine and blood clotting. EU to revise recommendation

    Munir, M.

    6/04/21

    1 Media production

    Press/Media: Research

  60. CoVAX and support to LMIC

    Munir, M.

    5/04/21

    1 Media production

    Press/Media: Research

  61. Situation of COVID-19 in Europe, AZ vaccine and blott clot and impact of Easter on virus emergence

    Munir, M.

    4/04/21

    1 Media production

    Press/Media: Research

  62. Vaccine mandate for general public

    Munir, M.

    2/04/21

    1 Media production

    Press/Media: Research

  63. Vaccine passport and scientific backing

    Munir, M.

    2/04/21

    1 Media production

    Press/Media: Research

  64. Let's go for a walk: Tide Bell and Giant Egg Walk

    Rigby, R.

    26/03/21

    1 Media production

    Press/Media: TV Interview/Appearance

  65. AstraZenca vaccine trial in USA, and Sputnik V vaccine has 92% efficacy and double mutant in India

    Munir, M.

    23/03/21

    1 Media production

    Press/Media: Research

  66. Vaccine induced prevention

    Munir, M.

    22/03/21

    1 Media production

    Press/Media: Research

  67. AstraZenca vaccine and reputation

    Munir, M.

    20/03/21

    1 Media production

    Press/Media: Research

  68. Parasites may make dogs smell good to insect vector

    Hamilton, G.

    18/03/21

    1 Media production

    Press/Media: Research

  69. Vaccine passport

    Munir, M.

    18/03/21

    1 Media production

    Press/Media: Research

  70. Shortage of vaccine in the UK for the month of April 2021

    Munir, M.

    18/03/21

    1 Media production

    Press/Media: Research

  71. Situation in Europe

    Munir, M.

    17/03/21

    1 Media production

    Press/Media: Research

  72. COVID19 VACCINE PASSPORTS

    Munir, M.

    17/03/21

    1 Media production

    Press/Media: Research

  73. Situation in the EU and UK with blood clots reported with AstraZeneca vaccine

    Munir, M.

    11/03/21

    1 Media production

    Press/Media: Research

  74. CoVID-19 in UK and france.

    Munir, M.

    10/03/21

    1 Media production

    Press/Media: Research

  75. Situation of COVID-19 in the UK

    Munir, M.

    3/03/21

    1 Media production

    Press/Media: Research

  76. New variant Dialogue

    Munir, M.

    3/03/21

    1 Media production

    Press/Media: Research

  77. Trial of VH6, and nasal vaccine

    Munir, M.

    3/03/21

    1 Media production

    Press/Media: Research

  78. Royal Lancaster Infirmary to trial a COVID-19 test

    Munir, M.

    2/03/21

    1 Media production

    Press/Media: Newspaper Article

  79. J&J Vaccine to be considered by FDA, CoVAX deliver first vaccine to Ghana

    Munir, M.

    27/02/21

    1 Media production

    Press/Media: Research

  80. WHO sent delegate to Wuhan to identify the origin of SARS-CoV-2

    Munir, M.

    15/02/21

    1 Media production

    Press/Media: Research

  81. Innovative new 20-minute COVID-19 test begins large-scale testing

    Munir, M.

    28/01/21

    1 Media production

    Press/Media: Newspaper Article

  82. Scientists developing Covid-19 vaccine nasal spray

    Munir, M.

    13/01/21

    1 Media production

    Press/Media: Newspaper Article

  83. Vaccines in the developing world

    Munir, M.

    30/12/20

    1 Media production

    Press/Media: Research

  84. December 2020

    Munir, M.

    30/12/20

    1 Media production

    Press/Media: Research

  85. Vaccines and vaccination in the UK

    Munir, M.

    30/12/20

    1 Media production

    Press/Media: Research

  86. Astrazeneca vaccine provide 70% protection.

    Munir, M.

    23/11/20 → 30/12/20

    8 Media contributions

    Press/Media: Research

  87. Highest cases in the UK and future prospects

    Munir, M.

    29/12/20

    1 Media production

    Press/Media: Research

  88. New variant and vaccine effectiveness

    Munir, M.

    29/12/20

    1 Media production

    Press/Media: Research

  89. 53,432 cases are reported in the UK - highest since the start of the pandemic - role of new variant and vaccines

    Munir, M.

    29/12/20

    1 Media production

    Press/Media: Research

  90. ABC TV Australia on B.1.1.7 variant and vaccination

    Gatherer, D.

    28/12/20

    1 Media production

    Press/Media: TV Interview/Appearance

  91. New variant and change in control measures

    Munir, M.

    26/12/20

    1 Media production

    Press/Media: Research

  92. New variant and global health

    Munir, M.

    25/12/20

    1 Media production

    Press/Media: Research

  93. New varriant and festive season

    Munir, M.

    25/12/20

    1 Media production

    Press/Media: Research

  94. New variant of SARS-CoV-2 in the UK and its impact on other countries

    Munir, M.

    20/12/20 → 23/12/20

    10 Media contributions

    Press/Media: Research

  95. Schools opening in January in the UK and new variant

    Munir, M.

    23/12/20

    1 Media production

    Press/Media: Research

  96. Comparative advantage of CoVID-19 vaccine and trust defiant in Chinese vaccines.

    Munir, M.

    23/12/20

    1 Media production

    Press/Media: Research

  97. UK and South African variant analysis

    Munir, M.

    23/12/20

    1 Media production

    Press/Media: Research

  98. Anwer public question on new variant

    Munir, M.

    23/12/20

    1 Media production

    Press/Media: Research

  99. Vaccine distribution and control of CoVID19

    Munir, M.

    22/12/20

    1 Media production

    Press/Media: Research

  100. Vaccines, School, Tests and new variants

    Munir, M.

    22/12/20

    1 Media production

    Press/Media: Research

Previous 1 2 3 4 5 6 7 8 Next

Back to top